Skip to main content
Clinical Trials/JPRN-jRCT2052220056
JPRN-jRCT2052220056
Active, not recruiting
未知

Safety and efficacy of the stabilizer device using in endovascular therapy - SD-01 Trial

Sakai Nobuyuki0 sites30 target enrollmentJune 22, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sakai Nobuyuki
Enrollment
30
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 22, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sakai Nobuyuki

Eligibility Criteria

Inclusion Criteria

  • 1 Patients aged between 20years and 80years old at the time of concent acquisition
  • 2 modified Rankin Scale is 3 or less
  • 3 Patients with cerebral aneurysm or cerebral artery stenosis who cannot deliver therapeutic medical devices by conventional methods including replacement during endovascular treatment
  • 4 patients who concented to the study in writing.

Exclusion Criteria

  • 1\.Heparin cannot be administered for medical reasons
  • 2\.It is difficult to follow up 7 days after surgery
  • 3\.Have a history of severe contrast agent allergies
  • 4\.The following patients who are contraindicated in the clinical trial device summary
  • (1\) Patients with allergies to metals contained in the investigational equipment The following patients who are contraindicated in the investigational equipment summary
  • (2\) Patients with carotid artery dissection, carotid cervical obstruction or vasculitis
  • 5\.Participating in other clinical trials
  • 6\.Pregnant or breastfeeding, or unwilling to use contraception during the trial (female only)
  • 7\.In addition, the investigator or the investigator has determined that it is inappropriate for conducting this clinical trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials